Today’s Digest is all about cows! Microbiome of healthy cows and cows developing postpartum endometritis, and metabolic pathways of rumen microbiota. Ok, almost. Find out whether anthropogenic radionuclides at Chernobyl (Ukraine) impact the gut microbiome of the bank vole. Also, there’s an interesting read on human microbiome and microbial metabolites that contribute to the accumulation of lipids in the liver. Happy week!

Animal microbiome

*Preprint: Delayed differentiation of vaginal and uterine microbiomes in dairy cows developing postpartum endometritis – Raúl Miranda-CasoLuengo – bioRxiv

Meta-proteomics of rumen microbiota indicates niche compartmentalisation and functional dominance in a limited number of metabolic pathways between abundant bacteria – E.H. Hart – Scientific Report

*Environmental radiation alters the gut microbiome of the bank vole Myodes glareolus – Anton Lavrinienko – The ISME Journal

The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus – Eldin Jašarević – Nature Neuroscience

Human microbiome

*Microbiome metabolomics reveals new drivers of human liver steatosis – Nathalie M. Delzenne – Nature Medicine

The gut–liver axis and the intersection with the microbiome – Anupriya Tripathi – Nature Reviews Gastroenterology & Hepatology

Longevity extension in Drosophila through gut-brain communication – Susan Westfall — Scientific Reports

Gut microbiota composition is related to cardiorespiratory fitness in healthy young adults – Ryan P. Durk – International Journal of Sport Nutrition and Exercise Metabolism

Microbes in the news

Data on transfer of gut microbiota from hen to chick can inform probiotic R&D [A Czech team’s research findings provide insights for the development of next generation probiotics for poultry production in the absence of antibiotics.] – Jane Byrne

*The future of the microbiome: A conversation with Michael Fischbach [Discussion on the growing knowledge of the bacteria in our bodies, their role in our health, and how researchers like Fischbach are shaping the future of microbiome-mediated disease therapy.] – Russ Altman